India’s pharma sector bullish on export growth
- IBEF
- January 6, 2026
The pharmaceutical industry in India is optimistic about future growth and increased export activity. Exports were approximately Rs. 2.51 lakh crore (US$ 30.47 billion) during FY 2024–25, marking a 9.4% year-on-year increase, as per an annual report that was issued by the Pharmaceutical Export Promotion Council of India (PHARMEXCIL). During an interaction with the Commerce Secretary of India, PHARMEXCIL stated that exports are expected to exceed the previous fiscal year’s export numbers before the end of the current financial year, demonstrating the ongoing success and overall strength of Indian pharmaceutical exports. The fact that over 150 countries have access to quality-assured Indian pharmaceuticals further supports the Indian pharmaceutical export industry.
PHARMEXCIL held discussions with high-level representatives from the Central Government, where they reviewed trends in export performance, policy support, and strategic priorities to increase exports and market presence internationally. They also discussed the current size of the Indian Pharmaceutical Market, estimated to be Rs. 4.95 lakh crore (US$ 60 billion), and its expected growth to Rs.10.82 lakh crore (US$130 billion) by 2030 as demand increases. The positive outlook for exports is due to high international demand for Indian-made pharmaceuticals, ongoing policy discussions, and coordination among the various industry associations and government entities involved in advancing India's pharmaceutical exporting capability. Stakeholders in the sector anticipate that continued collaboration among the stakeholders will further enhance the momentum of the export sector and position India within the global pharmaceutical supply chain.
Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.
Partners
